How to Use AI Across the TPLC to Accelerate Safe Product Delivery 10x

Last year, 42% of companies abandoned their AI initiatives, more than double the rate from the year before (S&P Global). Getting from a great demo to real value inside a regulated workflow is hard, and the teams that cross that gap aren't separated by their model or their budget.

In this session, we'll show you how leading MedTech teams are solving it. We'll cover building continuous compliance across FDA, EU MDR, and the EU AI Act with up to 90% less documentation overhead. We'll look at using AI for change impact analysis and end-to-end traceability, and how to enforce your QMS directly inside Jira, Git, and the tools your developers already use. We'll close with real-world case studies from enterprise MedTech teams putting AI into production today.

‍